Company intelligence / Profile preview

Kelusa Capital

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Kelusa Capital is a healthcare-focused investment firm that provides strategic capital and operational support to early-stage and growth-stage companies in the life sciences and biotechnology sectors. Founded by James Tananbaum, the firm specializes in identifying transformative medical technologies and therapeutic platforms with the potential to significantly improve patient outcomes. Kelusa Capital often serves as a precursor or strategic partner to larger investment vehicles, leveraging its deep industry expertise to foster innovation in its portfolio companies. The firm remains an active participant in the global healthcare investment landscape, focusing on high-impact opportunities in drug discovery and medical devices.

Industry: Investors

Beyond the preview

Go deeper on Kelusa Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kelusa Capital.

Explore the full profile